• $17.5M
    Market Cap
  • -25.70%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
09/30/2023
09/30/2022
Income Statement
Total Operating Revenue
17.9B
+77,464.18%
23.0M
-28.74%
32.3M
-19.52%
40.1M
-16.34%
Cost of Revenue
11.6B
+68,075.93%
17.0M
-22.92%
22.0M
+20.50%
18.3M
-19.44%
Gross Profit
6.3B
+103,675.87%
6.1M
-41.14%
10.3M
-52.88%
21.9M
-13.56%
Sales and Marketing Expense
4.8B
+58,615.42%
8.2M
+20.45%
6.8M
-64.45%
19.1M
+541.77%
Research and Development Expense
-671.8M
+22,062.17%
-3.0M
-37.61%
-4.9M
-36.44%
-7.6M
+39.86%
Depreciation and Amortization Expense
517.4M
+106,425.59%
485,734
-4.53%
508,785
-4.71%
533,949
+19.48%
Total Operating Expenses
9.2B
+65,307.73%
14.1M
+1.80%
13.8M
-52.81%
29.3M
+149.92%
Operating Profit
-2.9B
+36,258.82%
-8.0M
+127.40%
-3.5M
-55.83%
-8.0M
-158.75%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-289.4M
N/A
N/A
N/A
-156,788
-3.46%
-162,400
+59.84%
Interest Income and Expense and Net
-289.4M
N/A
0
+100.00%
-156,788
-3.46%
-162,400
+59.84%
Total Nonoperating Income and Expense
-756.1M
+750,377.40%
-100,754
-68.79%
-322,800
-40.81%
-545,349
-717.34%
Income before Taxes
-3.7B
+45,119.04%
-8.1M
+110.95%
-3.8M
-51.78%
-8.0M
-158.37%
Income Taxes
N/A
N/A
606,704
-73.78%
2.3M
+207.47%
752,419
-68.10%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.7B
+41,975.51%
-8.7M
+41.61%
-6.2M
-29.46%
-8.7M
-177.18%
Net Income from Continuing Operations Applicable to Common
-3.7B
+45,119.04%
-8.1M
+110.95%
-3.8M
-51.78%
-8.0M
-158.37%
Basic EPS and Net Income
-8.06
-98.71%
-626.96
+36,780.00%
-1.70
+325.00%
-0.40
-166.67%
Diluted EPS and Net Income
-8.06
-98.71%
-626.96
+36,780.00%
-1.70
+325.00%
-0.40
-166.67%
Basic Weighted Average Shares
455,871
+3,174.94%
13,920
-99.62%
3.6M
-83.33%
21.8M
+14.59%
Diluted Weighted Average Shares
455,871
+3,174.94%
13,920
-99.62%
3.6M
-83.33%
21.8M
+14.59%
Balance Sheet
Cash and Cash Equivalents
33.6B
+113,780.18%
29.5M
+458.11%
5.3M
-7.46%
5.7M
-29.30%
Short-Term Investments
N/A
N/A
N/A
N/A
13.2M
+0.54%
13.1M
-4.20%
Cash and Cash Equivalents and Short-Term Investments
33.6B
+113,780.18%
29.5M
+59.41%
18.5M
-1.89%
18.9M
-13.50%
Total Current Assets
53.6B
+103,707.08%
51.6M
+40.28%
36.8M
-11.31%
41.5M
-17.78%
Accumulated Depreciation
6.9B
+103,485.84%
6.7M
+10.15%
6.1M
+5.96%
5.7M
-1.21%
Property and Plant and Equipment and Net
3.6B
+100,334.50%
3.6M
-3.57%
3.7M
-12.96%
4.3M
-9.20%
Total Long-Term Assets
15.7B
+96,125.43%
16.3M
-0.98%
16.5M
-8.64%
18.0M
-8.29%
Total Assets
69.3B
+101,886.72%
68.0M
+27.52%
53.3M
-10.50%
59.5M
-15.12%
Income Taxes Payable
640.8M
+62,648.92%
1.0M
+134.88%
434,758
+159.79%
167,350
-84.81%
Total Short-Term Debt
9.3B
+319,104.10%
2.9M
-47.10%
5.5M
-25.06%
7.3M
+68.01%
Total Current Liabilities
13.2B
+64,754.77%
20.3M
+47.68%
13.8M
+5.01%
13.1M
+16.83%
Total Long-Term Debt
2.1B
+98,475.66%
2.1M
N/A
N/A
N/A
3.4M
+17,033.62%
Total Long-Term Liabilities
2.1B
+13,949.76%
15.0M
N/A
N/A
N/A
N/A
N/A
Total Liabilities
13.2B
+58,580.02%
22.5M
+63.22%
13.8M
+5.01%
13.1M
+16.83%
Retained Earnings
-13.8B
+136,001.17%
-10.2M
-200.12%
10.2M
-37.76%
16.3M
-34.86%
Total Stockholders Equity
56.1B
+123,253.59%
45.5M
+15.10%
39.5M
-14.88%
46.4M
-21.20%
Total Shares Outstanding
563,338
+1,213.75%
42,880
-98.82%
3.6M
-83.33%
21.8M
0.00%
Cash Flow
Cash from Operating Activities
-5.1B
+53,044.92%
-9.5M
-948.75%
1.1M
+185.35%
-1.3M
-36.17%
Capital Expenditures
266.8M
+127,958.28%
208,320
+371.64%
44,169
-52.86%
93,703
-78.92%
Cash from Investing Activities
-341.8M
+94,508.69%
-361,285
+717.96%
-44,169
-98.87%
-3.9M
-85.56%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.7B
+28,544.75%
34.0M
+2,541.62%
-1.4M
-141.91%
3.3M
-87.52%
Financials Ratio
Gross Margin
35.28%
+33.79%
26.37%
-17.40%
31.93%
-41.45%
54.53%
N/A
Operating Margin
-16.33%
-53.12%
-34.83%
+219.09%
-10.92%
-45.12%
-19.89%
N/A
Return on Assets
-10.59%
-26.46%
-14.40%
+31.78%
-10.92%
-18.92%
-13.47%
N/A
Return on Equity
-13.07%
-36.31%
-20.53%
+43.17%
-14.34%
-13.54%
-16.58%
N/A
Revenue Growth
77,464.18%
+269,670.96%
-28.74%
+47.24%
-19.52%
+19.46%
-16.34%
N/A
Current Ratio
4.07
+60.06%
2.54
-5.01%
2.68
-15.55%
3.17
N/A
Cash Ratio
2.55
+75.59%
1.45
+277.88%
0.38
-11.88%
0.44
N/A
Debt-to-Equity Ratio
0.20
+82.93%
0.11
N/A
N/A
N/A
0.23
N/A
Debt-to-Assets Ratio
0.16
+121.32%
0.07
N/A
N/A
N/A
0.18
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow